stem cell gene therapy (Wooridul Life Sciences)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namestem cell gene therapy (Wooridul Life Sciences)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionBone modulatorsStem cells modulators
TargetsUpdating
Therapy Area/IndicationsFractures, BoneSpinal Cord Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesWoodridul Huebrain
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWoodridul Huebrain
Active IndicationsN/A
Inactive IndicationsFractures, BoneSpinal Cord Injuries

Other Information

ATC CodeN/A
Related LinksN/A